ICUI Quote, Financials, Valuation and Earnings

Perspective Therapeutics, Inc. has a net margin of -0.63% compared to ICU Medical, Inc.'s net margin of -12425.36%. ICU Medical, Inc.'s return on equity of -0.36% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.

ICU Medical, Inc. has a consensus price target of $180.83, signalling upside risk potential of 22.6%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 331.85%. Given that Perspective Therapeutics, Inc. has higher upside potential than ICU Medical, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than ICU Medical, Inc..

ICU Medical, Inc. has a beta of 0.823, which suggesting that the stock is 17.719% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.

ICU Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.

ICU Medical, Inc. quarterly revenues are $537.7M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. ICU Medical, Inc.'s net income of -$3.4M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, ICU Medical, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical, Inc. is 1.56x versus 184.77x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Merit Medical Systems, Inc. has a net margin of -0.63% compared to ICU Medical, Inc.'s net margin of 7.22%. ICU Medical, Inc.'s return on equity of -0.36% beat Merit Medical Systems, Inc.'s return on equity of 8.28%.

ICU Medical, Inc. has a consensus price target of $180.83, signalling upside risk potential of 22.6%. On the other hand Merit Medical Systems, Inc. has an analysts' consensus of $103.60 which suggests that it could grow by 18.22%. Given that ICU Medical, Inc. has higher upside potential than Merit Medical Systems, Inc., analysts believe ICU Medical, Inc. is more attractive than Merit Medical Systems, Inc..

ICU Medical, Inc. has a beta of 0.823, which suggesting that the stock is 17.719% less volatile than S&P 500. In comparison Merit Medical Systems, Inc. has a beta of 0.615, suggesting its less volatile than the S&P 500 by 38.504%.

ICU Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Merit Medical Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical, Inc. pays -- of its earnings as a dividend. Merit Medical Systems, Inc. pays out -- of its earnings as a dividend.

ICU Medical, Inc. quarterly revenues are $537.7M, which are larger than Merit Medical Systems, Inc. quarterly revenues of $384.3M. ICU Medical, Inc.'s net income of -$3.4M is lower than Merit Medical Systems, Inc.'s net income of $27.8M. Notably, ICU Medical, Inc.'s price-to-earnings ratio is -- while Merit Medical Systems, Inc.'s PE ratio is 44.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical, Inc. is 1.56x versus 3.60x for Merit Medical Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

TriSalus Life Sciences, Inc. has a net margin of -0.63% compared to ICU Medical, Inc.'s net margin of -93.47%. ICU Medical, Inc.'s return on equity of -0.36% beat TriSalus Life Sciences, Inc.'s return on equity of --.

ICU Medical, Inc. has a consensus price target of $180.83, signalling upside risk potential of 22.6%. On the other hand TriSalus Life Sciences, Inc. has an analysts' consensus of $11.50 which suggests that it could grow by 63.12%. Given that TriSalus Life Sciences, Inc. has higher upside potential than ICU Medical, Inc., analysts believe TriSalus Life Sciences, Inc. is more attractive than ICU Medical, Inc..

ICU Medical, Inc. has a beta of 0.823, which suggesting that the stock is 17.719% less volatile than S&P 500. In comparison TriSalus Life Sciences, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

ICU Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TriSalus Life Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical, Inc. pays -- of its earnings as a dividend. TriSalus Life Sciences, Inc. pays out -- of its earnings as a dividend.

ICU Medical, Inc. quarterly revenues are $537.7M, which are larger than TriSalus Life Sciences, Inc. quarterly revenues of $11.6M. ICU Medical, Inc.'s net income of -$3.4M is higher than TriSalus Life Sciences, Inc.'s net income of -$10.8M. Notably, ICU Medical, Inc.'s price-to-earnings ratio is -- while TriSalus Life Sciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical, Inc. is 1.56x versus 5.79x for TriSalus Life Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -0.63% compared to ICU Medical, Inc.'s net margin of 3.93%. ICU Medical, Inc.'s return on equity of -0.36% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

ICU Medical, Inc. has a consensus price target of $180.83, signalling upside risk potential of 22.6%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 92.31%. Given that Xtant Medical Holdings, Inc. has higher upside potential than ICU Medical, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than ICU Medical, Inc..

ICU Medical, Inc. has a beta of 0.823, which suggesting that the stock is 17.719% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

ICU Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

ICU Medical, Inc. quarterly revenues are $537.7M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. ICU Medical, Inc.'s net income of -$3.4M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, ICU Medical, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical, Inc. is 1.56x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.